Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
859.9000
11.65
(
1.37
%)
NSE
Dec 19, 2025
15:31 PM
Volume:
65,161
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alembic Pharmaceuticals Ltd.
05 Feb 2024
US FDA Approval
859.90
1.37%
India/export formulation drive earnings
Neutral:
Alembic Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 910
Target
Motilal Oswal
Alembic Pharmaceutic.. has an
average target
of 1028.50 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - December 19, 2025
The Baseline |
19 Dec 2025, 05:15PM
Market closes higher on softer US inflation and foreign investor buying
Trendlyne Marketwatch |
19 Dec 2025, 03:55PM
Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
|
22 Jul 2020